Score Overview
See the full market ranking โ
AtriCure Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 206M to $ 534M and net income went from -$ 48M to -$ 11M. Revenue increased in every one of those 5 years; net income in 3.
Between 2015 and 2025, revenue grew from $ 129M to $ 534M and net income went from -$ 27M to -$ 11M. Revenue increased in 9 of those 10 years; net income in 6.
AtriCure Inc currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 43.56 | โ |
1 Year2025-08-12 | $ 35.84 | 21.54% |
5 Years2021-08-12 | $ 73.56 | -40.78% |
10 Years2016-08-12 | $ 15.48 | 181.40% |
20 Years2006-08-11 | $ 5.44 | 8x |
All Time2005-08-05 | $ 14.08 | 209.38% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2005-08-05 |
|---|---|---|---|---|---|---|
| Price | $ 43.56 | $ 35.84 | $ 73.56 | $ 15.48 | $ 5.44 | $ 14.08 |
| Return | โ | 21.54% | -40.78% | 181.40% | 8x | 209.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 569M | $ 10M | $ 167M |
| 2025 | $ 534M | -$ 11M | $ 167M |
| 2024 | $ 465M | -$ 44M | $ 122M |
| 2023 | $ 399M | -$ 30M | $ 137M |
| 2022 | $ 330M | -$ 46M | $ 121M |
| 2021 | $ 274M | $ 50M | $ 119M |
| 2020 | $ 206M | -$ 48M | $ 244M |
| 2019 | $ 230M | -$ 35M | $ 81M |
| 2018 | $ 201M | -$ 21M | $ 124M |
| 2017 | $ 174M | -$ 26M | $ 34M |
| 2016 | $ 155M | -$ 33M | $ 44M |
| 2015 | $ 129M | -$ 27M | $ 34M |
| 2014 | $ 107M | -$ 16M | $ 59M |
| 2013 | $ 81M | -$ 11M | $ 26M |
| 2012 | $ 70M | -$ 7M | $ 12M |
| 2011 | $ 64M | -$ 5M | $ 14M |
| 2010 | $ 59M | -$ 3M | $ 12M |
| 2009 | $ 54M | -$ 16M | $ 15M |
| 2008 | $ 55M | -$ 10M | $ 11M |
| 2007 | $ 48M | -$ 11M | $ 20M |
| 2006 | $ 38M | -$ 13M | $ 19M |
| IPO2005 | $ 30M | -$ 12M | $ 33M |
Explore beyond ATRC
You're looking at AtriCure Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Becton Dickinson and CompanyBDXยท revenue grew in 75% of years
- Waters CorporationWATยท revenue grew in 75% of years
- Integra LifeSciences HoldingsIARTยท revenue grew in 85% of years
- Rigel Pharmaceuticals IncRIGLยท revenue grew in 56% of years
- Aurinia Pharmaceuticals IncAUPHยท revenue grew in 55% of years
